TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
European Drug Testing Service EDTS AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
110,169
|
128,446
|
125,957 |
| Financial expenses |
79
|
106
|
137 |
| Earnings before taxes |
37,202
|
17,713
|
4,356 |
| EBITDA |
35,041
|
16,257
|
4,601 |
| Total assets |
139,294
|
106,836
|
95,837 |
| Current assets |
139,244
|
106,591
|
95,103 |
| Current liabilities |
26,428
|
25,421
|
29,363 |
| Equity capital |
109,390
|
79,963
|
65,990 |
| - share capital |
345
|
345
|
345 |
| Employees (average) |
28
|
27
|
27 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
78.5%
|
74.8%
|
68.9% |
| Turnover per employee |
3,935
|
4,757
|
4,665 |
| Profit as a percentage of turnover |
33.8%
|
13.8%
|
3.5% |
| Return on assets (ROA) |
26.8%
|
16.7%
|
4.7% |
| Current ratio |
526.9%
|
419.3%
|
323.9% |
| Return on equity (ROE) |
34.0%
|
22.2%
|
6.6% |
| Change turnover |
-18,277
|
2,489
|
18,039 |
| Change turnover % |
-14%
|
2%
|
17% |
| Chg. No. of employees |
1
|
0
|
-4 |
| Chg. No. of employees % |
4%
|
0%
|
-13% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.